Development and validation of Burkholderia pseudomallei-specific real-time PCR assays for clinical, environmental or forensic detection Applications by Price, Erin P. et al.
Development and Validation of Burkholderia
pseudomallei-Specific Real-Time PCR Assays for Clinical,
Environmental or Forensic Detection Applications
Erin P. Price1,2, Julia L. Dale1, James M. Cook1, Derek S. Sarovich1,2, Meagan L. Seymour1,
Jennifer L. Ginther1, Emily L. Kaufman1, Stephen M. Beckstrom-Sternberg1,3, Mark Mayo2,
Mirjam Kaestli2, Mindy B. Glass4, Jay E. Gee4, Vanaporn Wuthiekanun5, Jeffrey M. Warner6,
Anthony Baker6, Jeffrey T. Foster1, Patrick Tan7, Apichai Tuanyok1, Direk Limmathurotsakul5,
Sharon J. Peacock5,8,9, Bart J. Currie2, David M. Wagner1, Paul Keim1,3, Talima Pearson1*
1Center for Microbial Genetics and Genomics, Northern Arizona University, Flagstaff, Arizona, United States of America, 2Menzies School of Health Research, Casuarina,
Northern Territory, Australia, 3 Translational Genomics Research Institute, Phoenix, Arizona, United States of America, 4Centers for Disease Control and Prevention,
Atlanta, Georgia, United States of America, 5Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand,
6Microbiology and Immunology, School of Veterinary and Biomedical Sciences, James Cook University, Townsville, Queensland, Australia, 7Genome Institute of
Singapore, Singapore, Singapore, 8Department of Microbiology and Immunology, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand, 9Department of
Medicine, University of Cambridge, Cambridge, United Kingdom
Abstract
The bacterium Burkholderia pseudomallei causes melioidosis, a rare but serious illness that can be fatal if untreated or
misdiagnosed. Species-specific PCR assays provide a technically simple method for differentiating B. pseudomallei from near-
neighbor species. However, substantial genetic diversity and high levels of recombination within this species reduce the
likelihood that molecular signatures will differentiate all B. pseudomallei from other Burkholderiaceae. Currently available
molecular assays for B. pseudomallei detection lack rigorous validation across large in silico datasets and isolate collections
to test for specificity, and none have been subjected to stringent quality control criteria (accuracy, precision, selectivity, limit
of quantitation (LoQ), limit of detection (LoD), linearity, ruggedness and robustness) to determine their suitability for
environmental, clinical or forensic investigations. In this study, we developed two novel B. pseudomallei specific assays,
122018 and 266152, using a dual-probe approach to differentiate B. pseudomallei from B. thailandensis, B. oklahomensis and
B. thailandensis-like species; other species failed to amplify. Species specificity was validated across a large DNA panel
(.2,300 samples) comprising Burkholderia spp. and non-Burkholderia bacterial and fungal species of clinical and
environmental relevance. Comparison of assay specificity to two previously published B. pseudomallei-specific assays,
BurkDiff and TTS1, demonstrated comparable performance of all assays, providing between 99.7 and 100% specificity
against our isolate panel. Last, we subjected 122018 and 266152 to rigorous quality control analyses, thus providing
quantitative limits of assay performance. Using B. pseudomallei as a model, our study provides a framework for
comprehensive quantitative validation of molecular assays and provides additional, highly validated B. pseudomallei assays
for the scientific research community.
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Introduction
The Burkholderia genus contains over 60 species, some of which
are of environmental, clinical or forensic importance. With the
exception of the obligate mammalian pathogen, B. mallei, the
Burkholderia spp. reside in many different environmental niches that
include fresh and salt water, soil, and the plant rhizosphere [1,2].
Certain Burkholderia spp. including B. ambifaria, B. anthina, B.
cenocepacia, B. cepacia, B. dolosa, B. mallei, B. multivorans, B.
oklahomensis, B. pseudomallei, B. pyrrocinia, B. stabilis, B. thailandensis,
B. ubonensis and B. vietnamiensis have been shown to cause
opportunistic infections in humans [1,2,3,4,5]. Of these species,
B. pseudomallei is of greatest clinical relevance, being the most
common cause of fatal community-acquired bacteremia in
northeast Thailand [6] and fatal community-acquired bacteremic
pneumonia in Northern Australia [7]. B. pseudomallei and B. mallei
are important from a forensic standpoint due to the disease
severity caused by these species and their bioweaponization
potential, with both species listed as Category B Select Agents by
the Centers for Disease Control and Prevention (http://www.bt.
cdc.gov/agent/agentlist-category.asp).
B. pseudomallei may not be readily identifiable from clinical,
forensic or environmental samples based on culturing alone, as
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multiple morphotypes exist for this species, even within the same
strain [8,9]. Further, many Burkholderia spp. co-reside with B.
pseudomallei in the environment and can appear morphologically
and serologically similar to B. pseudomallei, even when using
selective culture media, or biochemical and serological tests
designed to solely detect B. pseudomallei [10,11]. Latex agglutination
methods are routinely used in endemic areas such as Thailand and
northern Australia and have shown good, but not perfect,
specificity for B. pseudomallei [12]. Accurate identification of B.
pseudomallei is particularly difficult in non-endemic regions where
selective media are typically not used to isolate B. pseudomallei and
technicians lack the experience required to identify putative B.
pseudomallei isolates. Therefore, positive B. pseudomallei identification
cannot be based solely on phenotypic characteristics and
molecular characterization is a necessary component of definitive
species assignment [13].
Two striking features of B. pseudomallei are its genetic and
genomic heterogeneity [14,15,16,17] and high rates of recombi-
nation [18]. These factors render accurate B. pseudomallei
identification using molecular methods a non-trivial endeavor. A
number of B. pseudomallei-specific molecular signatures have been
described in the literature [13,19,20,21,22,23,24,25,26]. The vast
majority of these signatures, however, have been identified using
limited in silico comparative genomic data; the likelihood of false-
positive (i.e. shared with neighboring species) and false-negative
(i.e. not universally found within the target species) signatures is
therefore reasonably high. Compounding this issue, few signatures
have been tested against Burkholderia and non-Burkholderia spp.
panels that adequately sample existing genetic diversity and,
therefore, more accurately validate specificity. Indeed, one
promising species-specific B. pseudomallei signature [24] gave
multiple false-positive results following screening across a more
diverse species panel [27]. It is thus difficult to develop 100%
accurate B. pseudomallei-specific assays despite the importance of
this bacterium from a clinical, environmental and forensic stance.
The current ‘gold standard’ species-specific assay for B.
pseudomallei relies on amplification of orf2 of the type three
secretion system 1 (TTS1) cluster, which is only present in B.
pseudomallei [13]. More recently, the BurkDiff assay was developed
as a dual-probe TaqMan assay to differentiate B. pseudomallei from
B. mallei [27]. Both TTS1 and BurkDiff have been tested against
Burkholderia and non-Burkholderia spp. strain panels of moderate size
and have shown promising speciation accuracy. However,
although the TTS1 and BurkDiff assays appear to be highly
reliable for identification of B. pseudomallei [13,23,26,27,28,29],
both assays give null results for other Burkholderia spp. that can
phenotypically resemble B. pseudomallei, such as B. thailandensis, B.
thailandensis-like species [30], B. oklahomensis, B. vietnamiensis or B.
ubonensis [11,31,32,33], meaning that these other Burkholderia
species often go unidentified and thus their true incidence is
largely unknown. In addition, neither assay has been comprehen-
sively validated against a wide range of rigorous performance
criteria [34], although both assays have demonstrated an
impressive limit of detection [13,27], and for TTS1, high
selectivity in complex clinical and environmental specimens
[13,26,35].
Based on these existing knowledge gaps, the high predicted
likelihood that any B. pseudomallei specific assay will sometimes
produce false results and the importance of robust detection assays
for clinical, environmental and forensic purposes, our aims were as
follows. First, to identify B. pseudomallei-specific single nucleotide
polymorphisms (SNPs) using whole genome sequence (WGS) data,
with a view to providing additional speciation markers that enable
differentiation of B. pseudomallei from B. mallei, B. thailandensis, B.
oklahomensis and B. thailandensis-like species. Second, to develop real-
time PCR assays for these targets using the robust dual-probe
TaqMan [36] format. Third, to screen our TaqMan B. pseudomallei
assays, and the TTS1 and BurkDiff assays, across an extensive
panel of 2,332 Burkholderia spp. and non-Burkholderia DNA to
determine specificity. Last, to quantitatively assess the accuracy,
specificity, precision, selectivity, limit of quantitation (LoQ), limit
of detection (LoD), linearity, ruggedness and robustness of our
TaqMan assays by pushing them to their performance limits,
which provides important information on assay performance for
downstream applications.
Materials and Methods
Bacterial growth conditions and DNA preparation
All Burkholderia spp., with the exception of B. mallei, were
cultured on Luria Bertani (LB) agar (Becton Dickinson, Franklin
Lakes NJ); B. mallei LB plates were further supplemented with 4%
vol/vol glycerol (Thermo Fisher Scientific, Pittsburgh PA) [37].
Burkholderia DNA extractions were performed from pure cultures as
previously described [38]. For non-Burkholderia bacterial species,
cultures were grown using appropriate agar and atmospheric
conditions (Hardy Diagnostics, Santa Maria, CA; Becton Dick-
inson) and extracted using either the Gram-positive or Gram-
negative protocols of the DNeasy Blood and Tissue kit (Qiagen,
Valencia CA), as appropriate. For Staphylococcus and Streptococcus
species, lysostaphin or mutanolysin (Sigma-Aldrich, St Louis, MO)
was added to the DNeasy lysis buffer, respectively, to improve
extraction efficiency. For yeast and fungal species, we used the
DNeasy Blood and Tissue kit (Qiagen) as per manufacturer’s
instructions for yeast extraction. All DNA samples were quantified
using a NanoDrop 8000 spectrophotometer (Thermo Fisher
Scientific) and normalized to either 1 or 2 ng/mL in 16 TE
(pH 8.0; Thermo Fisher Scientific) for direct use in PCR.
SNP discovery
B. pseudomallei-specific SNP signatures were identified using a
two-pronged approach. First, we used an in-house pipeline [18] to
identify orthologous SNP loci among 35 Burkholderia genomes (24
B. pseudomallei (1026b, 1106a, 1106b, 112, NCTC 13177, 14,
MSHR1655, 1710a, 1710b, 22, MSHR305, 406e, 576, 668, 7894,
9, 91, B7210, BCC215, DM98, E208, K96243, Pasteur 52237 and
S13), six B. thailandensis (381, 700388, Bt4, TXDOH, E254 and
E264), two B. oklahomensis (C6786 and EO147), and one each of B.
dolosa (AUO158), B. ubonensis (Bu) and B. thailandensis-like MSMB
43 [30]. BLAST [39] analysis was performed on candidate SNP
loci to identify SNPs in genetic regions absent in B. mallei. This
additional filter was performed because the B. pseudomallei clade
includes B. mallei [40]. As a result, many evolutionarily stable SNP
alleles shared among all B. pseudomallei will also be shared with B.
mallei and, therefore, will not be B. pseudomallei-specific. Second, we
validated species specificity by comparing potential B. pseudomallei-
specific signatures in silico against all available B. pseudomallei, B.
mallei, B. thailandensis, B. thailandensis-like, B. vietnamiensis, B.
oklahomensis, B. ubonensis and B. cepacia genomes (as of September
2010). Of five shortlisted signatures (chosen for the conserved
nature of their surrounding sequence), only two (122018 and
266152) were investigated further as the others lacked specificity
for B. pseudomallei upon BLAST analysis across these other
Burkholderia spp.
Assay design and PCR conditions
The B. pseudomallei-specific SNPs 122018 and 266152 (arbitrarily
named) are bi-allelic, with B. pseudomallei containing one SNP state
Speciation of Burkholderia pseudomallei
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and B. thailandensis, B. oklahomensis and B. thailandensis-like species
containing the alternate state. Other Burkholderiaceae possess
additional SNPs or indels that would adversely affect binding of
the B. pseudomallei-specific probe according to in silico analysis.
Once in silico B. pseudomallei specificity was determined, the SNP
signatures were converted to TaqMan MGB probe format [36].
TaqMan probes and primers (Table 1) were designed using Primer
Express v3.0 software (Applied Biosystems, Foster City CA). All
primers and probes were subject to BLAST analysis to confirm
specificity. PCRs were performed in 384-well optical plates using
16 TaqMan Universal PCR Master Mix (Applied Biosystems),
primers and probes, and molecular-grade H2O (Invitrogen). One
mL DNA template (equating to 2 ng, or 2.56105 genomic
equivalents) was added per reaction to a final volume of 10 mL.
All reactions were carried out in dual-probe format and in
duplicate using 2 ng DNA template (1 ng template was used for
specificity screening), unless otherwise specified. For the 122018
assay, primer and probe concentrations were 0.3 mM and 0.1 mM,
respectively, whereas the 266152 assay used concentrations at
0.3 mM and 0.2 mM, respectively. Thermocycling was conducted
using default conditions (2 min at 50uC, 10 min at 95uC followed
by 40 cycles of denaturation for 15 s at 95uC and annealing and
extension for 1 min at 60uC) on a 7900HT Real-Time PCR
System (Applied Biosystems).
Previously established B. pseudomallei-specific assays
Genotyping calls for the 122018 and 266152 assays were
compared with two established B. pseudomallei-specific real-time
PCR assays, BurkDiff [27] and TTS1 [13], to determine the
specificity of all four assays (see ‘Assay quality performance’ below
for details). BurkDiff is a dual-probe TaqMan assay that
differentiates B. pseudomallei and B. mallei; other Burkholderia spp.
fail to amplify due to high levels of sequence diversity. We made a
modification to the BurkDiff assay (0.2 mM each primer/reaction
rather than the 0.9 mM previously reported) to improve assay
efficiency. TTS1 is a single probe assay that detects the presence or
absence of B. pseudomallei; the gene targeted by this assay is absent
in other Burkholderia spp. [13]. We performed TTS1 detection
essentially as described elsewhere [41] but with the following
alterations: we maintained the originally described primer and
probe concentrations [13], and used default thermocycling
parameters on the AB7900HT instrument for consistency with
the 122018 and 266152 assays.
Assay quality performance
To determine the suitability of our new B. pseudomallei-specific
assays over a wide range of conditions, we tested the performance
of the 122018 and 266152 assays across several criteria; accuracy,
specificity, precision, selectivity, LoQ, LoD, linearity, ruggedness
and robustness (Methods S1). We designed quality performance
experiments based on standardized definitions of these parameters
[34]. Two representative samples, B. pseudomallei 104 and B.
thailandensis-like MSMB 43, were used to test parameters due to
inherent differences in probe efficiencies between these different
species. Species specificity for the 122018 and 266152 assays was
determined by screening them across our entire Burkholderia DNA
collection, which comprises 2,205 Burkholderia spp. samples
(Table 2), normalized to 1 ng/mL using the NanoDrop 8000
instrument. We also tested these assays across 127 common soil,
water or clinically important prokaryotic and eukaryotic species to
confirm specificity (Table S2). A 466 bp real-time SYBR Green
16 S PCR [42] was used to confirm DNA integrity in instances
where no amplification with the B. pseudomallei assays was
observed, including fungal and yeast species, which amplified
(albeit less robustly, but above NTC signal) with this primer set,
probably due to non-specific amplification of other rRNA regions.
NTCs were included as cycles-to-threshold controls due to delayed
but positive amplification using AmpliTaq Gold polymerase,
which contains endogenous E. coli 16 S RNA.
DNA Sequencing
When species determination discrepancies among the 122018,
266152, BurkDiff and TTS1 assays were observed, samples were
subjected to multilocus sequence typing (MLST) [40] or 16 S
sequencing [42]. Sequencing of the 266152 locus in B. pseudomallei
Bp5706 was carried out by amplifying a ,400 bp fragment that
encompassed the 68 bp PCR product generated by the 266152
TaqMan assay to examine primer- or probe-binding mutations.
Big Dye v3.1 chemistry (Applied Biosystems) was used for cycle
sequencing. Sequencing products were denatured in Hi-Di
Table 1. B. pseudomallei 122018 and 266152 assays designed in this study.
Assay Primers and probes (59-39)a SNP locationb Expected polymorphismc
122018
CCTGATCGCCCGTCTTCG 3,713,843 (Chr1) T = B. pseudomallei
CGCAAAACTTTCTGGGGTAGT C=other species
6FAM-CCAGCGATTTGTTGAA
VIC-CAACGACTTGTTGAAC
266152
aataaatcataaACGTGAGGCCGGAGATGT 846,056 (Chr2) T = B. pseudomallei
aataaatcataaGACCGACATCACGCACAGC C=other species
VIC-CGGTCTACACGCATGA
6FAM-CGGTCTACACGCACGA
aUnderlined nucleotides indicate the position of the SNP in the TaqMan probe; lowercase nucleotides indicate a deliberately incorporated 59 flap to enhance
amplification efficiency [43].
bBased on B. pseudomallei K96243 genome (GenBank Accession numbers BX571965 and BX571966 for chromosomes 1 and 2, respectively) [14].
c‘Other species’ refers specifically to B. thailandensis, B. oklahomensis and B. thailandensis-like spp. B. mallei and other Burkholderia spp. (e.g. B. vietnamiensis, B. ubonensis
etc.) do not amplify according to in silico and wet-bench analyses.
doi:10.1371/journal.pone.0037723.t001
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formamide (Applied Biosystems) prior to electrophoresis on a 3130
or 3730 xl DNA Analyzer (Applied Biosystems).
Results and Discussion
Accuracy of 122018 and 266152 assays
Accuracy is the measure of exactness of an analytical method, or
the closeness of agreement between the measured value and the
value that is accepted as a conventional true value or an accepted
reference value [34], and is thus distinct from specificity and
precision (see Methods S1 for definitions). We subjected the
122018 and 266152 SNP signatures to both in silico and laboratory
screening to determine their accuracy towards B. pseudomallei.
BLAST analysis was carried out at the 122018 and 266152 loci
against all available B. pseudomallei, B. mallei, B. thailandensis, B.
thailandensis-like, B. vietnamiensis, B. oklahomensis, B. ubonensis and B.
cepacia genomes, which confirmed that only B. pseudomallei strains
possessed the B. pseudomallei-specific allele at these loci. We then
compared in silico and wet-bench genotypes using a panel of 13
whole genome-sequenced Burkholderia strains (Table S1). As
predicted from in silico analysis, both assays amplified the B.
pseudomallei-specific allele in all B. pseudomallei DNA samples, with
no detectable amplification in the four B. mallei samples (results not
shown). For 122018, both probes were specific to the appropriate
species, with no cross-hybridization of the alternate probes
(Figure 1). For 266152, B. oklahomensis, B. thailandensis and B.
thailandensis-like species possessed some cross-hybridization with
the B. pseudomallei probe but were distinguishable from B.
pseudomallei due to preferential amplification of the non-B.
pseudomallei probe (Figure 2).
Specificity of 122018, 266152, BurkDiff and TTS1 assays
Following confirmation of assay accuracy, we screened DNA
panels comprising 2,205 Burkholderia spp. (Table 2) and 127 non-
Burkholderia species (Figure S1; Table S2) with the 122018, 266152,
BurkDiff and TTS1 assays to determine their specificity. BurkDiff
and TTS1 have previously demonstrated specificity for B.
pseudomallei across moderately large DNA panels [13,27]. As
expected, the TTS1 assay showed excellent specificity for B.
pseudomallei, although we detected one false-negative B. pseudomallei
isolate, Bp1186 (original ID: SBCT-RF80-BP1, isolated from soil
in Northeast Thailand). Further investigation of Bp1186 showed
that it possessed a smaller genome than other B. pseudomallei strains,
and lacked certain virulence loci, including bimA and other TTS1
loci besides orf2. These findings suggest that Bp1186 is probably
unable to establish human infection (A. Tuanyok, unpublished
data). Assay 266152 gave a single ambiguous call in B. pseudomallei
Bp5706 (original ID: MSHR 1559) (0.05% of total samples) in
which both probes amplified at the same time, albeit poorly. DNA
sequence analysis of this isolate uncovered a second SNP (T/C)
6 bp upstream of the targeted SNP (result not shown). This SNP
was within the probe binding site and thus altered probe-binding
efficiency. No false-positives were detected using the TTS1 or
266152 assays.
BurkDiff was the only assay we examined that yielded no false-
positives or false-negatives across our DNA panels. In contrast,
using 122018, we observed six false-positives (0.3%) and no false-
negatives. None of the other B. pseudomallei-specific assays gave
detectable amplification of these six samples, indicating incorrect
species assignment by 122018. Sequencing for 16 S rDNA and
MLST confirmed one isolate as B. vietnamiensis and five as B.
ubonensis. Twenty-seven other B. ubonensis and one other B.
vietnamiensis did not amplify with the 122018 assay, suggesting
variable prevalence of a B. pseudomallei-like locus within these
species. All non-Burkholderia isolates were PCR-negative using the
four assays.
Although BurkDiff provided the best speciation performance
across our DNA panel, it was the most difficult assay to interpret
due to heavy cross-hybridization between probes. Using pure B.
pseudomallei templates, we observed a difference of CT (DCT) of
approximately 1, even with optimization measures employed for
improving amplification efficiency (results not shown). Despite this
very low DCT we did not encounter an inconsistent genotyping
call, indicating that this assay is robust in the presence of pure
templates. Unlike BurkDiff, TTS1-positive genotypes were readily
identifiable due to the single-probe format and amplification
efficiency of this assay. However, one drawback of this single-
probe format is that low-level cross contamination of B. pseudomallei
DNA in non-B. pseudomallei templates can cause false-positive PCR
results, and thus positive results must be interpreted with caution,
especially when high CT values are obtained. The 122018 and
266152 assays in their dual-probe format were not influenced by
low-level B. pseudomallei contamination in B. thailandensis, B.
oklahomensis and B. thailandensis-like templates, although low-level
contamination of B. pseudomallei DNA in e.g. B. ubonensis samples
remains problematic. Coupled with large DCT values, the
competitive dual-probe format enabled the most facile differenti-
ation between B. pseudomallei and non-B. pseudomallei templates
(Figures 1 and 2; Figures S2 and S3, Panel G).
Our results indicate that, with the exception of BurkDiff, no
single genotyping method was 100% effective at speciating B.
pseudomallei. Many promising molecular markers in Burkholderia spp.
are homoplastic [18,27]. Homoplastic markers may not be
apparent when screening assays across relatively small (,1,000)
isolate collections but can lead to false-positive and false-negative
Table 2. Burkholderia spp. DNA specificity panel used in this
study.
Burkholderia speciesa No. samples
B. pseudomallei 1,954
B. thailandensis 86
B. mallei 76
B. ubonensis 32
B. thailandensis-like/B. thailandensis/B. oklahomensisb 28
B. spp.c 13
B. cepacia 6
B. oklahomensis 4
B. vietnamiensis 2
B. thailandensis-like 2
B. cenocepacia 1
B. phytofirmans 1
Total 2,205
aAccording to genotyping results generated in the current study, 16 S
sequencing or MLST.
bPreviously identified as ‘Burkholderia spp.’ and renamed Burkholderia
thailandensis/B. thailandensis-like/B. oklahomensis based on their genotyping
outcomes in this study. However, we could not accurately differentiate these
three species as they all amplify the non-B. pseudomallei probe in the 122018
and 266152 assays. Neither TTS1 nor BurkDiff assays amplify B. thailandensis, B.
thailandensis-like or B. oklahomensis species, and thus could not be used for
species assignment.
cRuled out as being B. pseudomallei, B. thailandensis, B. thailandensis-like, B.
oklahomensis, B. vietnamiensis and B. ubonensis but strongly suspected to be
Burkholderia spp. due to their amplification using B. vietnamiensis and B.
ubonensis-specific assays (Price et al., unpublished data).
doi:10.1371/journal.pone.0037723.t002
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(as shown by our 122018 assay and the TTS1 assay) genotyping
calls when assays are screened across larger and more diverse
DNA panels. Additional mutations in probe- or primer-binding
sites, such as observed with 266152, can cause aberrant
genotyping results in otherwise promising species-specific signa-
tures. In our study, we used a large amount of WGS data to
minimize the probability of including homoplastic markers or
SNPs with polymorphic flanking regions. As more WGS data for
Burkholderiaceae are generated, this approach will continue to
provide the most accurate speciation targets. Based on our
findings, it is our recommendation that speciation of B. pseudomallei
be based on at least two independent molecular markers, or a
single molecular marker when latex agglutination testing is used,
to ensure that false-negative and false-positive genotyping calls do
not lead to erroneous species designations.
Selectivity
The potential for near-neighbor contamination of DNA is a
concern in complex specimens, such as those of environmental,
clinical or forensic origin. We therefore performed a selectivity
experiment (Methods S1) on the 122018 and 266152 assays to
quantitatively assess their ability to detect minor B. pseudomallei
components in the presence of near-neighbor DNA. We mixed B.
pseudomallei and B. thailandensis-like templates in known ratios of
0:100, 10:90, 25:75, 50:50, 75:25, 90:10 and 100:0, respectively.
Both assays amplified the B. pseudomallei-specific probe (i.e. pure B.
pseudomallei template) more efficiently than the alternate probe (i.e.
pure B. thailandensis-like template) (Table S3; Figures 1 and 2). As
expected, both alleles amplified when in the presence of mixed
template (Table S3; Figures S2 and S3).
For the 122018 assay, all mixtures of both B. pseudomallei and B.
thailandensis-like templates could be reliably distinguished from
pure template at the lowest tested limit of selectivity (10%), and the
266152 assay was able to discriminate between pure B. pseudomallei
and B. thailandensis-like template present at 10%. However, the B.
thailandensis-like: B. pseudomallei mixtures at 50:50, 25:75 and 10:90
ratios were indistinguishable from pure B. pseudomallei template
using the 266152 assay (Figures S2 and S3; Table S3), indicating
that the 266152 assay is insensitive to detecting B. thailandensis-like
template when in the presence of 50% or greater B. pseudomallei
template. Given the primary focus on B. pseudomallei in our study,
we do not consider this result a failure in selectivity as we
demonstrated that both assays yielded a significant difference
(DCT s.2) between pure B. pseudomallei template and B.
pseudomallei containing B. thailandensis-like template at a minor
component of #10%.
Our experiments outline a rudimentary protocol for determin-
ing selectivity using TaqMan assays. Although beyond the scope of
the current study, future studies should ideally examine lower
minor component mixtures below 10% to determine the limit of
selectivity for the 122018 and 266152 assays. Selectivity experi-
ments using spiked environmental or clinical specimens, such as
soil or sputum samples, would shed further light on the true
selectivity performance of the 266152 and 122018 assays in the
presence of PCR inhibitors or complex DNA constituents. Use of a
single-probe approach may provide better detection of minor
components than dual-probe format, although we do not
recommend using the 266152 assay in a non-competitive format
due to cross-hybridization of the probes, which may result in false-
positive results.
Limits of quantitation and detection (LoQ and LoD)
We calculated the lower LoQ and LoD (Tables S4 and S5) using
pure DNA template for B. pseudomallei and B. thailandensis-like
species. The LoQ was defined as the lowest level of DNA detected
that provided an acceptable level of precision (i.e. 8/8 replicates
amplified with a CT standard deviation (s) ,0.8 from the mean
CT), whereas LoD was measured as the concentration of analyte
that gave rise to a signal significantly different from the negative
control (i.e. at least 2/8 replicates amplified, irrespective of s) [34].
We were not able to establish the upper LoD or LoQ as these
values were not reached using our highest DNA amount of 40 ng/
PCR. For the 122018 assay, the lower LoQ was $461025 ng
($40 fg, or 5 genomic equivalents (GEs)) and $400 fg (50 GEs)
Figure 1. 122018 TaqMan dual probe assay. Red, the B. pseudomallei-specific TaqMan probe amplifies only B. pseudomallei template; the non-
B.pseudomallei TaqMan probe (green) amplifies well with B. thailandensis and B. thailandensis-like species and weakly with B. oklahomensis templates
but not B. pseudomallei. Other Burkholderia spp. do not amplify with either probe.
doi:10.1371/journal.pone.0037723.g001
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for B. pseudomallei and B. thailandensis-like templates, respectively,
whereas the 266152 assay yielded LoQ values at $4 fg
(,0.5 GEs) and $4 ng (56105 GEs), respectively. The poor
LoQ value for B. thailandensis-like template using the 266152 assay
was surprising given that all eight replicates amplified at $400 fg
(50 GEs). Using our LoQ criteria, this assay is unreliable for
quantitating B. thailandensis-like DNA. The LoD of the 122018
assay was $4 fg (,0.5 GEs) and $40 fg (5 GEs) for B. pseudomallei
and B. thailandensis-like templates, respectively, and $4 fg total
DNA (,0.5 GEs) for both templates using the 266152 assay
(Table S5). These results contrast with LoD values previously
reported for the 266152 assay [35], which demonstrated a LoD of
10 GEs (see ‘Linearity’ below for further discussion on the 266152
results).
Although it is difficult to compare LoD values between studies
due to experimental design differences (e.g. number of replicates
tested, or differences in mastermix constituents, DNA quantita-
tion, instruments, or thermal conditions), TaqMan probes
theoretically have the capacity to reach 0.5 GEs (the equivalent
of a single PCR target) in a well-designed assay. The TTS1 assay
reportedly provides a LoD of 76 fg, or 10 GEs, in PCR and 122 fg
(16 GEs) in spiked human blood [13], and the BurkDiff assay
provides a LoD of 10 GEs in PCR [27]. Therefore, the LoD of our
dual-probe assays are similar in performance to TTS1 and
BurkDiff, particularly in the presence of B. pseudomallei template.
As expected, the LoD and LoQ of the B. thailandensis-like template
were less sensitive. Although not tested in the current study, the
LoD and LoQ of near-neighbor templates, such as B. thailandensis-
like species MSMB 43, could potentially be increased by using the
non-B. pseudomallei probe by itself to avoid competition issues with
the B. pseudomallei-specific probe.
Figure 2. 266152 TaqMan dual probe assay. Green, the B. pseudomallei-specific TaqMan probe preferentially amplifies B. pseudomallei template;
the non-B.pseudomallei TaqMan probe (red) amplifies well in B. thailandensis-like species and weakly in B. thailandensis and B. oklahomensis. Other
Burkholderia spp. do not amplify.
doi:10.1371/journal.pone.0037723.g002
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Linearity
We tested linearity of the 122018 and 266152 assays under
controlled conditions (see Methods S1 for details) to establish the
range of DNA amounts that enable accurate quantification [34].
Such information is valuable for quantifying the concentration of
uncharacterized samples, or for determining the lowest concen-
tration at which reliable genotyping data can be attained,
particularly when DNA is limiting.
We did not reach the upper limit of linearity using the highest
concentration of 40 ng DNA for either B. pseudomallei or B.
thailandensis-like templates, indicating that the range of linearity for
our assays is close to or greater than this amount. B. thailandensis-like
template linearity lacked precision across DNA concentrations,
particularly for assay 266152 (Table S6), indicating that the 266152
assay should not be used to quantify B. thailandensis-like DNA. The
lower-limit of linearity for B. pseudomallei, based on 100%
amplification across eight replicates and s,0.8 between replicates,
was 40 fg (5 GEs) and 4 fg (,0.5 GEs) for the 122018 and 266152
assays, respectively. In other words, our data indicate that B.
pseudomallei template can be accurately quantified down to 0.5 GEs
(as also observed in ‘LoQ’ above), which is equivalent to a single
PCR target, the theoretical limit of PCR detection. We have also
determined the LoD of the 266152 assay as 10 GEs [35]; however,
this value was based on 95% amplification success across 64
replicates, whereas the current study used only 25% amplification
success across eight replicates and was thus less stringent. DNA
quantitation varied between these two studies (NanoDrop spectro-
photometric quantitation vs. normalization against a 16 S rDNA
target), and it is possible that minor variations in DNA quantitation
or dilution preparation influenced our quantitation results. Never-
theless, we have demonstrated that these dual-probe assays possess a
large linearity range in the presence of pure B. pseudomallei templates
and can thus be used to precisely quantify unknown samples across
a wide range of DNA concentrations (Figure S4 and Table S6).
Determining linearity also allowed us to calculate the PCR
efficiency of the 122018 and 266152 assays. For the 122018 assay,
PCR efficiency was 91% and 89% for B. pseudomallei and B.
thailandensis-like templates, respectively. The efficiency of the
266152 assay was higher, at 97% and 94% for B. pseudomallei
and B. thailandensis-like templates, respectively (Table S6). In
contrast, the efficiency of the TTS1 assay has been reported at
99% for B. pseudomallei [13]. However, the linear range used in this
study was much more restrictive than ours due to the smaller
number of DNA concentrations included in the linear dynamic
range, so comparison of PCR efficiencies between studies must be
prudently interpreted. It remains to be determined whether PCR
efficiency for the 122018 and 266152 assays could be improved by
using single-probe format, as is used in the TTS1 assay.
Robustness and Ruggedness
Robustness and ruggedness are oft-neglected aspects of assay
performance, despite their inter-laboratory importance. We
therefore assessed these criteria for the 122018 and 266152 assays
using multiple AB7900HT instruments (ruggedness), and TaqMan
probe and Universal Master Mix (Applied Biosystems) reagent
lots, types of commercial mastermixes (Universal and Genotyping
Master Mixes; Applied Biosystems) and annealing/extension
temperatures (robustness) to determine those features most critical
to inter-laboratory assay transfer.
Comparison of commercial mastermixes with the 266152 and
122018 assays yielded unexpected results. The TaqMan Geno-
typing Master Mix (Applied Biosystems) showed poor amplifica-
tion with the 122018 and 266152 assays (results not shown),
despite its purported suitability for SNP genotyping applications
(http://products.invitrogen.com/ivgn/product/4371355). Due to
the proprietary nature of most commercial mastermixes, we were
unable to establish the component difference between the
Genotyping and Universal Master Mixes. However, the BurkDiff
assay does not amplify using the TaqMan Universal Master Mix
(results not shown), suggesting that neither mix is ideal for all SNP
genotyping applications. In contrast, we did not observe
differences in precision or accuracy of amplification using three
different AB7900HT instruments, nor did we identify perfor-
mance differences among two probe and four TaqMan Universal
Master Mix reagent lots (results not shown), suggesting that our
TaqMan assays can be reliably reproduced on this platform using
our reaction conditions. We did not test the assays on different
real-time PCR platforms. Thus, further studies are required to
determine their suitability on different real-time PCR instruments
and across other commercial mastermixes.
Although our TaqMan probes were specifically designed with an
optimal annealing/extension temperature of 60uC, inter-laboratory
differences in thermal block temperatures can potentially influence
genotyping calls. We therefore tested the robustness of the 122018 and
266152 assays across multiple annealing/extension temperatures and
observed their effect on accurately and precisely calling correct
genotypes. Overall, annealing/extension temperatures at 57.5 and
62.5uC still amplified templates and gave correct genotyping calls,
although we did observe differences in robustness at these altered
temperatures, particularly when the B. thailandensis-like template was
assessed (Table S7). For the 122018 assay, the 57.5uC annealing/
extension temperature was comparable in performance to 60uC,
whereas 62.5uC exhibited more amplification failures than at the lower
annealing/extension temperatures. In contrast, the 62.5uC and 60uC
annealing/extension temperatures for assay 266152 were comparable
in performance, whereas 57.5uC replicates gave poorer replicate
success, especially in the presence of B. thailandensis-like template. The
DCT values at 57.5uC and 62.5uC were smaller than those at 60uC,
demonstrating that 60uC is indeed the optimal temperature (Table S7)
although they did not result in an increase in cross-hybridization.
Importantly, no erroneous genotypes were observed at either the
reduced or elevated temperature for either assay, indicating that these
assays are tolerant to thermal block variations, but deviations from
60uC will result in a reduction in assay robustness and thus assays
should ideally be optimized on each individual instrument.
Conclusions
B. pseudomallei is an important pathogen from a clinical,
environmental and forensic stance. Correct identification of B.
pseudomallei requires molecular characterization due to shortcomings
with phenotypic speciation techniques. Identification and quantifica-
tion of B. pseudomallei from pure cultures through to complex soil or
sputum samples is dependent on a thorough understanding of the
limits of species-specific assays. Despite the plethora of B. pseudomallei
assays available, few if any have been subjected to rigorous
performance criteria. We therefore identified, designed and thor-
oughly tested two novel B. pseudomallei-specific molecular assays,
122018 and 266152, by subjecting them to several parameters:
accuracy, specificity, precision, selectivity, LoQ, LoD, linearity,
ruggedness and robustness. The accuracy and specificity of the
122018 and 266152 assays were compared with those of two well-
established B. pseudomallei assays, BurkDiff and TTS1. BurkDiff
provided the best specificity, with no false-positives or false-negatives
detected across 2,205 Burkholderia samples and 127 common soil, water
or clinical species. Assay 266152 provide a single ambiguous
genotyping call for a B. pseudomallei isolate, the TTS1 assay gave one
false-negative result, and the 122018 assay gave six false-positive calls
in certain B. ubonensis and B. vietnamiensis strains.
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As these four assays become more widely used, we have no
doubt that false-positives and false-negatives will be encountered;
however, our work suggests that this will be a rare occurrence and
false conclusions will be further minimized by including more than
one of these assays for speciation. Additional specificity testing of
TTS1, BurkDiff, 122018 and 266152 assays on different
Burkholderia species is important as such strains will provide more
informative false-positive rates due to their genetic relatedness to
B. pseudomallei. Likewise, further testing of B. pseudomallei isolates
using these four assays will increase the accuracy of false-negative
rates. Our assays demonstrated comparable LoD and LoQ
performance to the current ‘gold standard’ B. pseudomallei typing
techniques. Although assay parameters like ruggedness, robustness
and selectivity are not typically examined when developing and
validating molecular assays, we anticipate that our methods will
provide a framework for future studies where quantitative
measures of comparative assay performance are paramount. Last,
accurate standardization of input DNA is a crucial component of
assay performance yet is difficult for complex environmental or
clinical specimens where B. pseudomallei is usually isolated, due to
the non-homogeneous nature of these samples, the presence of
PCR inhibitors or the abundance of non-Burkholderia DNA. While
the tests of assay performance included here measure the effects of
many potential variables, this list is not comprehensive. As such,
users should be aware that other untested factors that might be
encountered when samples are extracted from complex environ-
ments may have an impact on assay performance.
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